Universal VLP-based flu vaccine:broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza a virus subtypes
Ended Project Grant Awarded Last action
- Award ID
- R44AI106145
- Recipient
-
Technovax Inc. UEI CQC1WKNLJC41
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,481,143
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $734,219 | |
| Original award | $746,924 |
Quick answers
Who received award R44AI106145?
R44AI106145 was awarded to Technovax Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2013.
How much is award R44AI106145 worth?
$1,481,143 has been obligated on R44AI106145.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award